Labshake search
Citations for Tocris :
51 - 100 of 213 citations for VIP Antagonist since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... AMPAR antagonists ZK200775 (2 nM, Tocris, Cat# 2345) and kynurenic acid (0.1 mM ...
-
bioRxiv - Neuroscience 2022Quote: ... or Drd4 antagonist (L-745,870, 50 nM, Tocris) to examine the dopaminergic signaling ...
-
bioRxiv - Neuroscience 2023Quote: The general dopamine receptor antagonist flupenthixol dihydrochloride (Tocris) was prepared at a concentration of 100 μM in sterile 0.9% saline and frozen in aliquots that were thawed fresh immediately prior to use ...
-
bioRxiv - Neuroscience 2023Quote: ... All agonists and antagonists were acquired from Tocris. Experiments were discontinued 3.5 h after slicing.
-
bioRxiv - Neuroscience 2023Quote: ... and 50 μM NMDA receptor antagonist AP5 (Tocris). Data were filtered at 4 kHz and digitized at 20 kHz using Digidata 1550B and Clampex software (Molecular Devices) ...
-
bioRxiv - Neuroscience 2023Quote: ... The antagonists were purchased from Tocris (Minneapolis, MN). All test compounds were dissolved in saline.
-
bioRxiv - Neuroscience 2023Quote: ... SHU9119 (MC3R/MC4R antagonist, Tocris, 3420, Batch 6A) was dissolved in ACSF at 0.5 nmol/μl and used for i.c.v ...
-
bioRxiv - Biophysics 2023Quote: ... or 20 µM of the antagonist LY341495 (Tocris) for normalization ...
-
bioRxiv - Neuroscience 2023Quote: ... AMPA receptor antagonist NBQX (20 μM, Tocris, 0373) and NMDA receptor antagonist APV (50 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... or antagonist CH 223191 (25 μM, Tocris 3858). All drugs were dissolved in DMSO ...
-
bioRxiv - Neuroscience 2023Quote: ... The dopamine D2-receptor antagonist raclopride (Tocris Bioscience) was used at a concentration of 100 μM ...
-
bioRxiv - Neuroscience 2023Quote: Microinjection of the D3R antagonist SB-277011A (Tocris) was used to pharmacologically inhibit D3R signaling in the NAc ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX (10 μM, Tocris; an AMPA receptor antagonist), glycine (10 μM ...
-
bioRxiv - Physiology 2024Quote: ... and antagonist L-745,870 (Tocris Bioscience, 1002/10)(43 ...
-
bioRxiv - Neuroscience 2024Quote: Oxytocin receptor antagonist (OTRA; L-368,899; Tocris 2641) was dissolved in saline 95% and DMSO 5% ...
-
bioRxiv - Neuroscience 2019Quote: ... the AMPA/kainate receptor antagonist 50μM NBQX (Tocris Bioscience) (Chandler et al. ...
-
bioRxiv - Neuroscience 2021Quote: ... the TrkB receptor antagonist ANA-12 (10 µM, Tocris), PKA inhibitor H89 (10 µM ...
-
bioRxiv - Microbiology 2021Quote: ... The TRPV1 antagonist A425619 (Tocris / Biotechne, Minneapolis, MN, USA) and the CGRP receptor anatagonist BIBN4096 (Sigma ...
-
Serotonin Modulates an Inhibitory Input to the Central Amygdala from the Ventral Periaqueductal GraybioRxiv - Neuroscience 2022Quote: ... 5HT2C receptor antagonist RS102221 (5 µM, Tocris, Minneapolis, MN) was added in the bath ...
-
bioRxiv - Neuroscience 2022Quote: ... AP5 + CNQX cocktail (NMDA and AMPA receptor antagonists; Tocris) or aCSF as vehicle control ...
-
bioRxiv - Neuroscience 2022Quote: ... adrenergic α1A receptor antagonist – RS17053 (40 μM, Tocris 0985); adrenergic α1B receptor antagonist – Chloroethylclonidine (30 μM ...
-
bioRxiv - Neuroscience 2022Quote: ... muscarinic acetylcholine receptor antagonist tiotropium bromide was from Tocris; 5-HT (100 μM ...
-
bioRxiv - Genomics 2023Quote: ... and the GABA-B receptor antagonist CGP55845 (Tocris #1246). Experiments with a series resistance of >15 MΩ or >20% change in series resistance were excluded from the final dataset ...
-
bioRxiv - Neuroscience 2023Quote: ... and AMPA/kainate antagonist CNQX (10 μM, Tocris Bioscience) were used to block ionotropic glutamatergic synaptic activity.
-
bioRxiv - Neuroscience 2023Quote: The GABAB-receptor antagonist CGP 54626 hydrochloride (Tocris Bioscience) was used at a concentration of 5 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... and NMDA receptor antagonist APV (50 μM, Tocris, 0106).
-
bioRxiv - Neuroscience 2019Quote: ... Receptor antagonists used this study included: GYKI-53655 (AMPAR; Tocris), LY341495 (group II mGluR ...
-
bioRxiv - Immunology 2019Quote: ... The potent PAFR antagonist Apafant was also purchased from Tocris and used at 40nM corresponding to 2xKi.
-
bioRxiv - Neuroscience 2021Quote: ... or the mGluR5 receptor antagonist MPEP (10 μM, Tocris, Germany) alone ...
-
bioRxiv - Neuroscience 2020Quote: ... The selective TRPA1 antagonist HC-030031 (10 µM; Tocris, USA) was used to validate the current.
-
bioRxiv - Neuroscience 2020Quote: ... cells were pre-blocked using EphA4 antagonist peptide (KYL; Tocris) or EphA2 monoclonal antibody (Abcam ...
-
bioRxiv - Neuroscience 2019Quote: ... the selective D3 receptor antagonist SB 27701A (5 µM; Tocris); the selective D4 receptor antagonist L-745 ...
-
bioRxiv - Cell Biology 2021Quote: A non-brain penetrable Y1 receptor antagonist BIBO3304 (Tocris Bioscience) was prepared in Milli Q water at a concentration of 1 mg/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... with mGluR1 antagonist (100μM LY357385, Tocris Bio-Techne, Minneapolis, MN), AMPA receptor blocker (5μM NBQX) ...
-
bioRxiv - Neuroscience 2020Quote: ... mGluR2/3 antagonist (1μM LY341495, Tocris Bio-Techne, Minneapolis, MN) and DGK inhibitor II (100 μM R59949 ...
-
bioRxiv - Neuroscience 2023Quote: ... CGP 71683 hydrochloride (NPY5R antagonist, Tocris, 2199, Batch 3B/275453) was dissolved in ACSF with 30% DMSO at a concentration of 5 nmol/μl and filtered ...
-
bioRxiv - Neuroscience 2023Quote: ... BIBP 3226 trifluoroacetate (NPY1R antagonist, Tocris, 2707, Batch 4A/263489) was dissolved in ACSF with 10% DMSO at a concentration of 5 nmol/μl and filtered (Millipore ...
-
bioRxiv - Neuroscience 2022Quote: ... a competitive GluN2A-favored NMDAR antagonist (Tocris, Ellisville, MI, USA), was dissolved in 0.9% sterile saline and stored frozen in 40–50 μl aliquots ...
-
bioRxiv - Neuroscience 2023Quote: The MCH receptor antagonist SNAP-94847 hydrochloride (Tocris Bioscience, 3347) was administered IP at a dose of 20 mg/kg ...
-
bioRxiv - Neuroscience 2023Quote: ... and P2Y12 antagonist PSB-0739 (Tocris Bioscience, UK, Catalog #3983) was administered at the dose of 0.1 mg/kg BW/day and 15 μg/day ...
-
bioRxiv - Cancer Biology 2024Quote: ... GABBR2 antagonist Baclofen (Tocris, 0417 at 10 and 100 μM) and SMOX inhibitor MDL72527 (Sigma ...
-
bioRxiv - Neuroscience 2021Quote: ... the OXT antagonist L-368,899 hydrochloride (Tocris Biosciences, 2641, 5 μM) and agonist WAY 267464 dihydrochloride (Tocris Biosciences ...
-
bioRxiv - Neuroscience 2019Quote: ... and CGP 52432 (selective GABAB receptor antagonist) were obtained from Tocris Bioscience (Ellisville ...
-
bioRxiv - Neuroscience 2019Quote: ... and the selective D2 antagonist sulpiride (10 µM; Tocris, Cat# 0895) were perfused for 10 min either before or after the GluN2B and GluN2A antagonists ...
-
bioRxiv - Neuroscience 2019Quote: ... the selective D1 antagonist SCH-23390 (10 µM; Tocris, Cat# 0925) and the selective D2 antagonist sulpiride (10 µM ...
-
bioRxiv - Neuroscience 2021Quote: ... SR95531 hydrobromide (Gabazine, GABAA receptor antagonist, 10 μM, Tocris Bioscience, UK) were used to block inhibitory synaptic transmission ...
-
bioRxiv - Cell Biology 2022Quote: ... Small molecule agonists and antagonists were purchased from Tocris (Minneapolis, MN) and dissolved in DMSO at 1000x the treatment concentration ...
-
bioRxiv - Neuroscience 2022Quote: ... the non-selective dopamine receptor antagonist Flupenthixol (15μg/.5μl/side; Tocris) or sterile saline (.5μL/side) ...
-
bioRxiv - Cancer Biology 2022Quote: ... NMDAR agonist (NMDA) and antagonist (L-AP5) were purchased from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Neuroscience 2022Quote: ... and adrenergic α1D receptors antagonist – BMY 7378 (10 μM, Tocris 1006).